These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


177 related items for PubMed ID: 17932854

  • 1. Efficacy of anterior chamber paracentesis after intravitreal triamcinolone injection.
    Chang W, Chung M.
    Eur J Ophthalmol; 2007; 17(5):776-9. PubMed ID: 17932854
    [Abstract] [Full Text] [Related]

  • 2. Effects of intravitreal injection of bevacizumab with or without anterior chamber paracentesis on intraocular pressure and peripapillary retinal nerve fiber layer thickness: a prospective study.
    Soheilian M, Karimi S, Montahae T, Nikkhah H, Mosavi SA.
    Graefes Arch Clin Exp Ophthalmol; 2017 Sep; 255(9):1705-1712. PubMed ID: 28616715
    [Abstract] [Full Text] [Related]

  • 3. [Variations in intraocular pressure (IOP) and necessity for paracentesis following intravitreal triamcinolone injection].
    Dwinger MC, Pieper-Bodeewes I, Eter N, Holz FG.
    Klin Monbl Augenheilkd; 2005 Aug; 222(8):638-42. PubMed ID: 16118744
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Safety profile of intravitreal triamcinolone acetonide.
    Baath J, Ells AL, Crichton A, Kherani A, Williams RG.
    J Ocul Pharmacol Ther; 2007 Jun; 23(3):304-10. PubMed ID: 17593015
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Intraocular pressure elevation after intravitreal or posterior sub-Tenon triamcinolone acetonide injection.
    Yamamoto Y, Komatsu T, Koura Y, Nishino K, Fukushima A, Ueno H.
    Can J Ophthalmol; 2008 Feb; 43(1):42-7. PubMed ID: 18204501
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. A prospective study of early intraocular pressure changes after a single intravitreal triamcinolone injection.
    Im L, Allingham RR, Singh I, Stinnett S, Fekrat S.
    J Glaucoma; 2008 Mar; 17(2):128-32. PubMed ID: 18344759
    [Abstract] [Full Text] [Related]

  • 17. Comparison of acetazolamide, brimonidine, and anterior chamber paracentesis for ocular hypertension control after initial intravitreal bevacizumab injection: a randomized clinical trial.
    Katayama BY, Bonini-Filho MA, Messias AM, Paula JS, Martin LF, Costa R, Jorge R.
    J Glaucoma; 2014 Sep; 23(7):461-3. PubMed ID: 23632404
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Secondary ocular hypertension after intravitreal injection of 4 mg of triamcinolone acetonide: incidence and risk factors.
    Vasconcelos-Santos DV, Nehemy PG, Schachat AP, Nehemy MB.
    Retina; 2008 Apr; 28(4):573-80. PubMed ID: 18398360
    [Abstract] [Full Text] [Related]

  • 20. Prophylactic selective laser trabeculoplasty in the prevention of intraocular pressure elevation after intravitreal triamcinolone acetonide injection.
    Bozkurt E, Kara N, Yazici AT, Yuksel K, Demirok A, Yilmaz OF, Demir S.
    Am J Ophthalmol; 2011 Dec; 152(6):976-981.e2. PubMed ID: 21861972
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.